Phosphorylation of Farnesoid X Receptor at Serine 154 Links Ligand Activation With Degradation.

Q Biochemistry, Genetics and Molecular Biology
Molecular endocrinology Pub Date : 2016-10-01 Epub Date: 2016-08-29 DOI:10.1210/me.2016-1105
Takuyu Hashiguchi, Shingo Arakawa, Shogo Takahashi, Frank J Gonzalez, Tatsuya Sueyoshi, Masahiko Negishi
{"title":"Phosphorylation of Farnesoid X Receptor at Serine 154 Links Ligand Activation With Degradation.","authors":"Takuyu Hashiguchi,&nbsp;Shingo Arakawa,&nbsp;Shogo Takahashi,&nbsp;Frank J Gonzalez,&nbsp;Tatsuya Sueyoshi,&nbsp;Masahiko Negishi","doi":"10.1210/me.2016-1105","DOIUrl":null,"url":null,"abstract":"<p><p>Comparison of 11 human nuclear receptor amino acid sequences revealed a conserved phosphorylation motif within their DNA-binding domains as an intramolecular signal that regulates proteolytic degradation. Nuclear receptors use this signal to either degrade or proscribe degradation through either the proteasome or nonproteasome pathways. A phosphomimetic farnesoid X receptor (FXR) S154D mutant neither bound to nor trans-activated an FXR-response element-driven reporter gene and was rapidly degraded in COS-1 cells. Ectopically expressed FXR had increased Ser154 phosphorylation in COS-1 cells after ligand treatment, and knock-down of the nuclear vaccinia-related kinase 1 (VRK1) greatly reduced this phosphorylation. FXR was phosphorylated at Ser154 in the nucleus of centrilobular hepatocytes only in ligand-treated mice. Thus, FXR Ser154 phosphorylation is a rheostat for activation and subsequent degradation that controls receptor levels and activity.</p>","PeriodicalId":18812,"journal":{"name":"Molecular endocrinology","volume":"30 10","pages":"1070-1080"},"PeriodicalIF":0.0000,"publicationDate":"2016-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1210/me.2016-1105","citationCount":"22","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1210/me.2016-1105","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2016/8/29 0:00:00","PubModel":"Epub","JCR":"Q","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 22

Abstract

Comparison of 11 human nuclear receptor amino acid sequences revealed a conserved phosphorylation motif within their DNA-binding domains as an intramolecular signal that regulates proteolytic degradation. Nuclear receptors use this signal to either degrade or proscribe degradation through either the proteasome or nonproteasome pathways. A phosphomimetic farnesoid X receptor (FXR) S154D mutant neither bound to nor trans-activated an FXR-response element-driven reporter gene and was rapidly degraded in COS-1 cells. Ectopically expressed FXR had increased Ser154 phosphorylation in COS-1 cells after ligand treatment, and knock-down of the nuclear vaccinia-related kinase 1 (VRK1) greatly reduced this phosphorylation. FXR was phosphorylated at Ser154 in the nucleus of centrilobular hepatocytes only in ligand-treated mice. Thus, FXR Ser154 phosphorylation is a rheostat for activation and subsequent degradation that controls receptor levels and activity.

Abstract Image

Abstract Image

淀粉样蛋白X受体丝氨酸154位点的磷酸化与配体激活和降解相关。
通过对11个人类核受体氨基酸序列的比较,发现其dna结合域内存在一个保守的磷酸化基序,作为调节蛋白水解降解的分子内信号。核受体利用该信号通过蛋白酶体或非蛋白酶体途径降解或禁止降解。一个拟磷法内酯X受体(FXR) S154D突变体既不结合也不反式激活FXR反应元件驱动的报告基因,并在COS-1细胞中迅速降解。在配体处理后,异位表达的FXR增加了COS-1细胞中Ser154的磷酸化,而核痘苗相关激酶1 (VRK1)的敲除大大降低了这种磷酸化。仅在配体处理的小鼠中,FXR在小叶中心肝细胞核中的Ser154位点被磷酸化。因此,FXR Ser154磷酸化是激活和随后降解的变阻器,控制受体水平和活性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molecular endocrinology
Molecular endocrinology 医学-内分泌学与代谢
CiteScore
3.49
自引率
0.00%
发文量
0
审稿时长
12 months
期刊介绍: Molecular Endocrinology provides a forum for papers devoted to describing molecular mechanisms by which hormones and related compounds regulate function. It has quickly achieved a reputation as a high visibility journal with very rapid communication of cutting edge science: the average turnaround time is 28 days from manuscript receipt to first decision, and accepted manuscripts are published online within a week through Rapid Electronic Publication. In the 2008 Journal Citation Report, Molecular Endocrinology is ranked 16th out of 93 journals in the Endocrinology and Metabolism category, with an Impact Factor of 5.389.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信